S
Shawn Malone
Researcher at Ottawa Hospital
Publications - 166
Citations - 5653
Shawn Malone is an academic researcher from Ottawa Hospital. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 30, co-authored 140 publications receiving 5015 citations. Previous affiliations of Shawn Malone include Ottawa Hospital Research Institute & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Roanne J. Segal,Robert D. Reid,Kerry S. Courneya,Shawn Malone,Matthew B. Parliament,Chris G. Scott,Peter Venner,H. Arthur Quinney,Lee W. Jones,Monika E. Slovinec D'Angelo,George A. Wells +10 more
TL;DR: Resistance exercise reduces fatigue and improves quality of life and muscular fitness in men with prostate cancer receiving androgen deprivation therapy and can be an important component of supportive care.
Journal ArticleDOI
Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate Cancer
Roanne J. Segal,Robert D. Reid,Kerry S. Courneya,Ronald J. Sigal,Glen P. Kenny,Denis G. Prud'Homme,Shawn Malone,George A. Wells,Chris G. Scott,Monika E. Slovinec D'Angelo +9 more
TL;DR: Both resistance and aerobic exercise mitigated fatigue in men with PCa receiving radiotherapy in the short term and generated longer-term improvements and additional benefits for QOL, strength, triglycerides, and body fat.
Journal ArticleDOI
Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions
Anthony V. D'Amico,James W. Denham,Juanita Crook,Ming-Hui Chen,Samuel Z. Goldhaber,David Lamb,David Joseph,Keen Hun Tai,Shawn Malone,Charles Ludgate,Allison Steigler,Philip W. Kantoff +11 more
TL;DR: The use of AST is associated with earlier onset of fatal MIs in men age 65 years or older who are treated for 6 months compared with men who are not treated with AST.
Journal ArticleDOI
Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
Juanita Crook,Christopher J. O'Callaghan,Graeme Duncan,David P. Dearnaley,Celestia S. Higano,Eric M. Horwitz,Eliot Frymire,Shawn Malone,Joseph L. Chin,Abdenour Nabid,Padraig Warde,Tom Corbett,S. Angyalfi,S.L. Goldenberg,Mary Gospodarowicz,Fred Saad,John P Logue,Emma Hall,Paul F. Schellhammer,Keyue Ding,Laurence Klotz +20 more
TL;DR: Intermittent androgen deprivation was noninferior to continuous therapy with respect to overall survival and some quality-of-life factors improved with intermittent therapy.
Journal ArticleDOI
Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients.
TL;DR: Post-RT prostate biopsies are not a gold standard of treatment efficacy, but are an independent predictor of outcome, and positive immunohistochemical staining for markers of cellular proliferation is associated with subsequent local failure.